Denali Therapeutics reported cash from operations of -$97.00M and free cash flow of -$97.81M for the quarter ended Jun 2026, down 28.8% year over year. This cash flow statement covers 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||||||
| Net Income | -84.59M | -75.26M | -66.50M | -58.79M | -103.30M | -98.68M | -109.78M | 183.38M | -99.35M | -119.47M | -101.80M | -99.03M | -107.19M | -114.69M | -132.97M | -124.12M | -126.90M | -128.45M | -128.45M | -127.55M | ||||||||||||||||||
| Share-based Compensation | 21.00M | 22.09M | 26.14M | 23.94M | 24.58M | 25.19M | 28.08M | 26.57M | 27.46M | 25.99M | 27.84M | 25.10M | 24.86M | 25.08M | 25.16M | 25.39M | 25.14M | 23.95M | 23.09M | 22.91M | ||||||||||||||||||
| Cash from Operations | -41.43M | -65.49M | -72.11M | -42.90M | -57.05M | -72.66M | -58.80M | -113.17M | -87.36M | -98.66M | -113.62M | -91.22M | -59.14M | -83.72M | -131.47M | -75.30M | -107.30M | -98.54M | -131.20M | -97.00M | ||||||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||||||||
| Amortizatization of Intangibles | 0.40M | 0.77M | 0.89M | 0.91M | 0.90M | 0.92M | 0.92M | 0.92M | ||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 2.19M | 2.10M | 2.08M | 2.07M | 2.14M | 4.11M | 10.05M | 2.29M | 2.22M | 2.18M | 2.16M | 1.94M | 1.84M | 1.86M | 2.33M | 3.04M | 2.95M | 2.88M | 2.85M | 3.57M | ||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||||||
| Change in Account Payables | 0.78M | -0.08M | 1.25M | 0.84M | 1.90M | -1.72M | 3.70M | 4.77M | -3.96M | -2.08M | 0.64M | 3.89M | -4.37M | 1.29M | -2.64M | 2.60M | -4.07M | -3.41M | 3.88M | 0.23M | ||||||||||||||||||
| Change in Accured Expenses | 6.49M | 7.77M | -8.31M | 5.87M | 9.33M | 4.03M | 19.81M | -32.21M | 0.73M | 14.31M | 2.32M | -20.82M | 24.59M | -2.84M | -9.69M | -4.46M | 1.89M | 12.73M | -22.39M | 3.29M | ||||||||||||||||||
| Other Working Capital Changes | -16.10M | 20.91M | -1.24M | 15.99M | -13.37M | 1.37M | 1.79M | -3.61M | -0.09M | 6.00M | 18.77M | 1.57M | -17.71M | -0.14M | 28.61M | -24.96M | -1.36M | -1.75M | 2.29M | 0.32M | ||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||||||
| Capital Expenditures | 1.88M | 3.05M | 4.04M | 2.89M | 6.05M | 4.85M | 6.08M | 2.56M | 2.07M | 2.23M | 2.15M | 4.79M | 3.88M | 5.09M | 5.08M | 4.28M | -1.38M | 1.52M | 2.47M | 0.81M | ||||||||||||||||||
| Change in Acquisitions & Divestments | 293.06M | 193.75M | 250.50M | 232.65M | 144.34M | 364.00M | 433.79M | 552.04M | 601.12M | 489.00M | 383.12M | 225.00M | 198.00M | 351.00M | 161.75M | 162.21M | 107.08M | 275.00M | 220.00M | 197.03M | ||||||||||||||||||
| Cash from Investing Activities | -53.01M | -40.75M | -117.88M | 88.63M | 15.42M | -127.56M | -92.72M | 168.07M | 100.91M | 73.05M | -453.19M | 98.57M | 93.66M | 172.21M | 18.75M | 157.94M | 57.83M | 20.77M | 94.46M | -104.08M | ||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||||||
| Other financing activities | 3.31M | 5.17M | 1.46M | 4.40M | 5.15M | 3.44M | 1.60M | 9.02M | 2.49M | 4.71M | 1.02M | 6.76M | 5.46M | 4.16M | 0.59M | 4.06M | 0.58M | 3.22M | 6.70M | 15.01M | ||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | ||||||||||||||||||||||||||||||||||||||
| Net Equity Issued and Repurchased | 499.25M | -499.25M | 189.25M | 12.37M | ||||||||||||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||||||||||||||
| Cash from Financing Activities | 3.31M | 5.17M | 1.46M | 4.40M | 5.15M | 299.65M | 1.60M | 9.02M | 2.49M | 4.71M | 500.27M | 6.76M | -18.56M | -4.17M | -3.76M | 1.62M | -0.78M | 192.13M | 219.04M | 14.98M | ||||||||||||||||||
| Change in Cash | -91.13M | -101.08M | -188.52M | 50.13M | -36.47M | 99.43M | -149.91M | 63.92M | 16.04M | -20.91M | -66.53M | 14.11M | 15.96M | 84.32M | -116.48M | 84.26M | -50.24M | 114.36M | 182.30M | -186.10M | ||||||||||||||||||
| Free Cash Flow | -43.31M | -68.55M | -76.15M | -45.79M | -63.10M | -77.51M | -64.88M | -115.73M | -89.43M | -100.89M | -115.77M | -96.01M | -63.02M | -88.81M | -136.55M | -79.58M | -105.92M | -100.06M | -133.67M | -97.81M | ||||||||||||||||||
| Net Cash Flow | -91.13M | -101.08M | -188.52M | 50.13M | -36.47M | 99.43M | -149.91M | 63.92M | 16.04M | -20.91M | -66.53M | 14.11M | 15.96M | 84.32M | -116.48M | 84.26M | -50.24M | 114.36M | 182.30M | -186.10M |